NATIONAL COUNCIL FOR PRESCRIPTION DRUG PROGRAMS INC — United States · Federal contract register · Supplier record: 42 contracts, all years ($5,427,082 · Aug 2006 – Jan 2025); $304K since January 2024 (2 contracts · 1 agency); — rank in the line (of 478 suppliers · 0.0%); 22 agencies never served ($630M on the line without NATIONAL COUNCIL FOR PRESCRIPTION DRUG PROGRAMS INC).
Assay record ASY-US-0JA6E630CW · Cite as: Assay Systems, “NATIONAL COUNCIL FOR PRESCRIPTION DRUG PROGRAMS INC: 2 government contracts in the United States since 2024”, https://assay-systems.com/register/us/national-council-for-prescription-drug-programs-inc/
42
contracts, all years
$5,427,082 · Aug 2006 – Jan 2025
$304K
since January 2024
2 contracts · 1 agency
—
rank in the line
of 478 suppliers · 0.0%
22
agencies never served
$630M on the line without NATIONAL COUNCIL FOR PRESCRIPTION DRUG PROGRAMS INC
Own record by year
2019 onward
$940K
$611K
$13.1K
$56.0K
$344K
$45.4K
$259K
20192020202120222023202420252026
Who buys from NATIONAL COUNCIL FOR PRESCRIPTION DRUG PROGRAMS INC
since January 2024
1agencies
$304Kpaid
100.0%top buyer
Department of Health and Human Services100.0%
$304,013
Before 2024 only: Department of Defense, Department of Labor, Department of Veterans Affairs, Federal Trade Commission, Government Accountability Office.
Won without a rival
2023-11-17 – 2025-10-02
10uncontested awards
100%of its awards
10without a competition
0single bid
NATIONAL COUNCIL FOR PRESCRIPTION DRUG PROGRAMS INC won 10 of its 10 public contract awards in United States without a rival from 2023-11-17 to 2025-10-02, worth $598K: 10 without a competition and 0 after a competition that drew a single bid. 6 buyers awarded it without a rival, the largest Office of the Assistant Secretary for Administration and Management with 3.
Source: USAspending.gov, U.S. Department of the Treasury, Bureau of the Fiscal Service, usaspending.gov, accessed 30 September 2026.The data is available to copy, adapt, redistribute, or otherwise use for non-commercial or for commercial purposes (USAspending.gov, Licensing); no Dun & Bradstreet data is shown.